N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors

Details for Australian Patent Application No. 2010317501 (hide)

Owner Pfizer Inc.

Inventors Bagley, Scott William; Griffith, David Andrew; Kung, Daniel Wei-Shung

Agent Shelston IP

Pub. Number AU-A-2010317501

PCT Pub. Number WO2011/058474

Priority 61/259,823 10.11.09 US

Filing date 29 October 2010

Wipo publication date 19 May 2011

International Classifications

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/058474 Priority application(s): WO2011/058474

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010317502-Determination of the quality of the seal of sealed capsules using a microwave resonator and related equipment for inline inspection

2010317485-Biomass fractionation process for bioproducts